soul trial oral semaglutide cardiovascular outcomes results 2025 Disease New in the May 29,
Description
But the existing research suggests the injections still work slightly better
[DOI] [PMC free article] [PubMed] [Google Scholar] Lon S, Benoit J, Clark S, Zizzari P, Yang B, Dugail I, Merabtene F, Clement K, Eygret L, Dupuy N, Delpech J-C, Rossitto M, Mack M, Lest-Lasserre T, Finan B, Cota D & Quarta C (2025) GLP-1-mediated targeting of inflammation corrects obesogenic memory in male mice
That reality, according to ONeil, paints a broader clinical picture: Weight gain is more than just a number on a scale
[DOI] [PMC free article] [PubMed] [Google Scholar] 40.Kadowaki T., Isendahl J., Khalid U., Lee S.Y., Nishida T., Ogawa W., Tobe K., Yamauchi T., Lim S., STEP 6 investigators Semaglutide once a week in adults with overweight or obesity, with or without type 2 diabetes in an east Asian population (STEP 6): A randomised, double-blind, double-dummy, placebo-controlled, phase 3a trial
Some patients may be missing out on treatment because they simply don't know they have coverage
Joseph Dayan: I could speculate, but I really don't know
